Lana X. Garmire
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lana X. Garmire has a total of 384 co-authors. Here are the top co-authors by number of shared publications:
- Travers Ching
University of Hawaii Cancer Center
22 shared publications Yuheng Du
Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, USA
20 shared publications- Bi-Dar Wang
Department of Pharmaceutical Sciences, School of Pharmacy and Health Professions, University of Maryland Eastern Shore, Princess Anne, MD 21853, USA
17 shared publications Jacqueline Olender
17 shared publicationsJohng Rhim
17 shared publications- Kaitlin Garofano
Department of Pharmacology and Physiology, The George Washington University School of Medicine and Health Sciences, GW Cancer Center, Washington, D. C
17 shared publications
Latest Publications
- Open Access
- 24 August 2026
- Published by Springer Nature in Nature Biomedical Engineering
- p. 1-17
HisToSpatialCNV: an interpretable deep learning method predicting spatial copy number variations from histopathology images
Copy number variations (CNV) are key drivers of cancer progression, yet methods for predicting spatial CNVs directly from haematoxylin and eosin (H&E) images are currently lacking. We introduce HisToSpatialCNV, a multiscale deep-learning framework that integrates histopathological features from H&E-stained images to infer spatial CNV patterns. Combining interpretable feature extraction with graph neural networks and multihead self-attention, our approach captures both local and global tissue contexts. Applied to HER2+ breast cancer, skin cancer and brain cancer datasets, HisToSpatialCNV outperformed existing methods for spatial gene expression inference and showed strong concordance between predicted CNVs and gene expression. In addition, it enabled tumour subclone identification, phylogenetic reconstruction and detection of pathway alterations linked to tumour progression. HisToSpatialCNV generalized across Visium and Xenium spatial transcriptomics platforms, on HER2+ patients. Applying the HisToSpatialCNV HER2+ model to TCGA HER2+ histopathology data identified spatial-molecular subtypes associated with distinct survival outcomes in TCGA HER2+ patients. By connecting histopathology to spatial genomics, HisToSpatialCNV offers a powerful, cost-effective tool for studying intratumour heterogeneity using only routine pathology images.
- 24 August 2026
- Published by Springer Nature in Nature Biomedical Engineering
- p. 1-17
Open AccessHisToSpatialCNV: an interpretable deep learning method predicting spatial copy number variations from histopathology images
Copy number variations (CNV) are key drivers of cancer progression, yet methods for predicting spatial CNVs directly from haematoxylin and eosin (H&E) images are currently lacking. We introduce HisToSpatialCNV, a multiscale deep-learning framework that integrates histopathological features from H&E-stained images to infer spatial CNV patterns. Combining interpretable feature extraction with graph neural networks and multihead self-attention, our approach captures both local and global tissue contexts. Applied to HER2+ breast cancer, skin cancer and brain cancer datasets, HisToSpatialCNV outperformed existing methods for spatial gene expression inference and showed strong concordance between predicted CNVs and gene expression. In addition, it enabled tumour subclone identification, phylogenetic reconstruction and detection of pathway alterations linked to tumour progression. HisToSpatialCNV generalized across Visium and Xenium spatial transcriptomics platforms, on HER2+ patients. Applying the HisToSpatialCNV HER2+ model to TCGA HER2+ histopathology data identified spatial-molecular subtypes associated with distinct survival outcomes in TCGA HER2+ patients. By connecting histopathology to spatial genomics, HisToSpatialCNV offers a powerful, cost-effective tool for studying intratumour heterogeneity using only routine pathology images.
- Open Access
HOMED enables hierarchical and multimodal optimization of DNA methylation deconvolution across tissues
Cellular heterogeneity is a major confounder in bulk DNA methylation data used in epigenome-wide association studies. Existing reference-based DNAm deconvolution methods often overlook hierarchical relationships among related cell types and may generalize poorly across datasets due to limited variability in reference profiles. We developed HOMED (Hierarchically Optimized Methylation Deconvolution) , a framework that integrates cell-type hierarchy, single-cell RNA sequencing-guided deconvolution, and paired bulk RNA-seq/DNAm data for CpG signature optimization. Across multiple simulated and real heterogeneous tissue datasets, HOMED achieved a 68% higher mean Pearson correlation coefficient (PCC) and 60% lower mean root mean squared error (RMSE), compared to other scRNA-seq-guided or single-cell DNA methylation-based DNAm deconvolution methods. Moreover, application of HOMED to a smoking-exposed placenta DNA methylation cohort revealed significant shifts in cell-type compositions in endothelial, nRBC, stromal, and villous trophoblast proportions. Adjusting for these compositional differences reduced inflated smoking-associated CpGs by nearly three folds, and doubled the number of enriched pathways with known associations to smoking. In summary, HOMED is an accurate and practical method to infer cell-type proportions from bulk DNA methylation data. Graphical
Open AccessHOMED enables hierarchical and multimodal optimization of DNA methylation deconvolution across tissues
Cellular heterogeneity is a major confounder in bulk DNA methylation data used in epigenome-wide association studies. Existing reference-based DNAm deconvolution methods often overlook hierarchical relationships among related cell types and may generalize poorly across datasets due to limited variability in reference profiles. We developed HOMED (Hierarchically Optimized Methylation Deconvolution) , a framework that integrates cell-type hierarchy, single-cell RNA sequencing-guided deconvolution, and paired bulk RNA-seq/DNAm data for CpG signature optimization. Across multiple simulated and real heterogeneous tissue datasets, HOMED achieved a 68% higher mean Pearson correlation coefficient (PCC) and 60% lower mean root mean squared error (RMSE), compared to other scRNA-seq-guided or single-cell DNA methylation-based DNAm deconvolution methods. Moreover, application of HOMED to a smoking-exposed placenta DNA methylation cohort revealed significant shifts in cell-type compositions in endothelial, nRBC, stromal, and villous trophoblast proportions. Adjusting for these compositional differences reduced inflated smoking-associated CpGs by nearly three folds, and doubled the number of enriched pathways with known associations to smoking. In summary, HOMED is an accurate and practical method to infer cell-type proportions from bulk DNA methylation data. Graphical
- Open Access
Placental molecular subtypes of severe preeclampsia reveal divergent aging trajectories and fetal growth outcomes
Severe preeclampsia (sPE) is a major cause of maternal and fetal morbidity worldwide, yet its placental molecular heterogeneity remains poorly defined by current clinical diagnosis. To resolve the molecular architecture of sPE, here we integrated DNA methylation and proteomic profiling from a multi-ethnic cohort of 444 placentas from the Hawaii Biorepository (HiBR), including 169 sPE cases, matched preterm controls and full-term controls. To address cellular heterogeneity in bulk placental tissue, we developed HOMED (Hierarchically Optimized Methylation Deconvolution), a single-cell-guided hierarchical framework for inferring placental cell-type composition from DNA methylation data. HOMED-adjusted integrative analyses identified extensive subtype-specific alterations involving hypoxia, angiogenesis, immune activation, trophoblast differentiation and metabolic remodeling. Molecular stratification revealed two reproducible sPE subtypes with divergent placental aging trajectories. One subtype exhibited a pre-mature placental state marked by accelerated placental aging, whereas the other displayed slower accelerated placental aging but a substantially increased risk of small-for-gestational-age birth (P = 0.028). These subtypes were independently replicated across six external cohorts and further supported by proteomic signatures achieving a classification accuracy of 0.88. Integrative epigenomic and proteomic analyses linked the growth-restricted subtype to hypoxia-associated glycolytic remodeling, suggesting distinct pathogenic mechanisms underlying clinically diagnosed sPE. Together, our findings redefine severe preeclampsia as a biologically heterogeneous placental disorder composed of molecularly distinct subtypes with divergent aging trajectories and fetal growth outcomes, providing a framework for mechanism-based stratification and precision obstetric medicine.
Open AccessPlacental molecular subtypes of severe preeclampsia reveal divergent aging trajectories and fetal growth outcomes
Severe preeclampsia (sPE) is a major cause of maternal and fetal morbidity worldwide, yet its placental molecular heterogeneity remains poorly defined by current clinical diagnosis. To resolve the molecular architecture of sPE, here we integrated DNA methylation and proteomic profiling from a multi-ethnic cohort of 444 placentas from the Hawaii Biorepository (HiBR), including 169 sPE cases, matched preterm controls and full-term controls. To address cellular heterogeneity in bulk placental tissue, we developed HOMED (Hierarchically Optimized Methylation Deconvolution), a single-cell-guided hierarchical framework for inferring placental cell-type composition from DNA methylation data. HOMED-adjusted integrative analyses identified extensive subtype-specific alterations involving hypoxia, angiogenesis, immune activation, trophoblast differentiation and metabolic remodeling. Molecular stratification revealed two reproducible sPE subtypes with divergent placental aging trajectories. One subtype exhibited a pre-mature placental state marked by accelerated placental aging, whereas the other displayed slower accelerated placental aging but a substantially increased risk of small-for-gestational-age birth (P = 0.028). These subtypes were independently replicated across six external cohorts and further supported by proteomic signatures achieving a classification accuracy of 0.88. Integrative epigenomic and proteomic analyses linked the growth-restricted subtype to hypoxia-associated glycolytic remodeling, suggesting distinct pathogenic mechanisms underlying clinically diagnosed sPE. Together, our findings redefine severe preeclampsia as a biologically heterogeneous placental disorder composed of molecularly distinct subtypes with divergent aging trajectories and fetal growth outcomes, providing a framework for mechanism-based stratification and precision obstetric medicine.
- 1 June 2026
- Published by Institute of Mathematical Statistics in The Annals of Applied Statistics
- Vol. 20 (2) , 1496-1515
BSNMani: Bayesian scalar-on-network regression with manifold learning
Brain connectivity analysis is crucial for understanding brain structure and neurological function, shedding light on the mechanisms of mental illness. To study the association between individual brain connectivity networks and the clinical characteristics, we develop BSNMani: a Bayesian scalar-on-network regression model with manifold learning. BSNMani comprises two components: the network manifold learning model for brain connectivity networks, which extracts shared connectivity structures and subject-specific network features, and the joint predictive model for clinical outcomes, which studies the association between clinical phenotypes and subject-specific network features while adjusting for potential confounding covariates. For posterior computation, we develop a novel two-stage hybrid algorithm combining Metropolis-Adjusted Langevin Algorithm (MALA) and Gibbs sampling. Our method is not only able to extract meaningful subnetwork features that reveal shared connectivity patterns but can also reveal their association with clinical phenotypes, further enabling clinical outcome prediction. We demonstrate our method through simulations and through its application to real resting-state fMRI data from a study focusing on Major Depressive Disorder (MDD). Our approach sheds light on the intricate interplay between brain connectivity and clinical features, offering insights that can contribute to our understanding of psychiatric and neurological disorders as well as mental health.
- 1 June 2026
- Published by Institute of Mathematical Statistics in The Annals of Applied Statistics
- Vol. 20 (2) , 1496-1515
BSNMani: Bayesian scalar-on-network regression with manifold learning
Brain connectivity analysis is crucial for understanding brain structure and neurological function, shedding light on the mechanisms of mental illness. To study the association between individual brain connectivity networks and the clinical characteristics, we develop BSNMani: a Bayesian scalar-on-network regression model with manifold learning. BSNMani comprises two components: the network manifold learning model for brain connectivity networks, which extracts shared connectivity structures and subject-specific network features, and the joint predictive model for clinical outcomes, which studies the association between clinical phenotypes and subject-specific network features while adjusting for potential confounding covariates. For posterior computation, we develop a novel two-stage hybrid algorithm combining Metropolis-Adjusted Langevin Algorithm (MALA) and Gibbs sampling. Our method is not only able to extract meaningful subnetwork features that reveal shared connectivity patterns but can also reveal their association with clinical phenotypes, further enabling clinical outcome prediction. We demonstrate our method through simulations and through its application to real resting-state fMRI data from a study focusing on Major Depressive Disorder (MDD). Our approach sheds light on the intricate interplay between brain connectivity and clinical features, offering insights that can contribute to our understanding of psychiatric and neurological disorders as well as mental health.
- Open Access
Machine Learning Estimation of Gestational Age at Delivery Using Linked Mother-Infant Electronic Health Records Across Two Health Systems
Objective: This study aimed to train and evaluate supervised machine learning walgorithms using electronic health record (EHR) data to accurately estimate gestational age at delivery. Materials and Methods: We trained random forest, gradient boosting, and ensemble models on EHR data of mother-infant dyads from Vanderbilt University Medical Center(VUMC) and replicated the analyses at University of Michigan (UMich). We further analyzed EHR predictors of gestational age, assessed temporal drift in EHR data elements, and evaluated model performance stratified by delivery status. Results: The study included pregnancies corresponding to 54,344 and 34,345 mother-infant dyads at VUMC (2005-2025) and UMich (2012-2024), respectively. The gestational age predictions of the ensemble models achieved the highest agreement with the reference standard on the VUMC dataset (±1 week: 85.2%, ±2 weeks: 94.3%, MAE: 4.4 days) and demonstrated stronger generalization on the UMich dataset (±1 week: 93.1%, ±2 weeks: 97.8%, MAE: 2.8 days). Further, performance was better among pregnancies delivered in more recent years, and among full- and late-term deliveries compared with preterm deliveries. Discussion: The results indicate that supervised machine learning methods leveraging linked mother-infant EHRs can accurately estimate gestational age at delivery, while demonstrating the generalizability of the modeling approach and the portability of the analytic workflow across healthcare sites. Conclusion: This study presents a robust and generalizable machine learning framework to estimate gestational age at delivery. The framework can be reliably used to impute gestational age in large-scale, real-world clinical studies to support maternal and neonatal health research, in which accurate estimation of pregnancy onset is critical.
Open AccessMachine Learning Estimation of Gestational Age at Delivery Using Linked Mother-Infant Electronic Health Records Across Two Health Systems
Objective: This study aimed to train and evaluate supervised machine learning walgorithms using electronic health record (EHR) data to accurately estimate gestational age at delivery. Materials and Methods: We trained random forest, gradient boosting, and ensemble models on EHR data of mother-infant dyads from Vanderbilt University Medical Center(VUMC) and replicated the analyses at University of Michigan (UMich). We further analyzed EHR predictors of gestational age, assessed temporal drift in EHR data elements, and evaluated model performance stratified by delivery status. Results: The study included pregnancies corresponding to 54,344 and 34,345 mother-infant dyads at VUMC (2005-2025) and UMich (2012-2024), respectively. The gestational age predictions of the ensemble models achieved the highest agreement with the reference standard on the VUMC dataset (±1 week: 85.2%, ±2 weeks: 94.3%, MAE: 4.4 days) and demonstrated stronger generalization on the UMich dataset (±1 week: 93.1%, ±2 weeks: 97.8%, MAE: 2.8 days). Further, performance was better among pregnancies delivered in more recent years, and among full- and late-term deliveries compared with preterm deliveries. Discussion: The results indicate that supervised machine learning methods leveraging linked mother-infant EHRs can accurately estimate gestational age at delivery, while demonstrating the generalizability of the modeling approach and the portability of the analytic workflow across healthcare sites. Conclusion: This study presents a robust and generalizable machine learning framework to estimate gestational age at delivery. The framework can be reliably used to impute gestational age in large-scale, real-world clinical studies to support maternal and neonatal health research, in which accurate estimation of pregnancy onset is critical.
- Open Access
Dissecting the coordinated progression of cell states in spatial transcriptomics with CoPro
Spatial transcriptomics enables the study of how cells coordinate their molecular states within tissue, providing insight into both normal function and disease processes. A key challenge is to identify gene expression programs that vary continuously across space and are coordinated between cell types. We present CoPro , a computational framework for detecting the spatially coordinated progression of cellular states. CoPro can operate in both supervised and unsupervised modes to identify gene programs that co-vary within or between cell types, and to disentangle multiple overlapping spatial patterns. CoPro can be applied to single-cell-level spatial transcriptomics datasets, including MERFISH, SeqFISH+, Xenium, and histology-imputed transcriptomic data. We demonstrate the utility of CoPro with data collected from colon, brain, liver, and kidney tissues. In the colon, CoPro separates epithelial differentiation along the crypt axis from spatially localized inflammatory signals. In the aging liver, it identifies multiple aging-associated cellular programs superimposed on anatomical zonation. In the brain, the flexible kernel design enables the decoupling of the gene expression gradient along the dorsal-ventral and medial-lateral axes. In the kidney, CoPro identifies tubule-vasculature coordination that is essential in nephron function. These results demonstrate CoPro’s utility for analyzing spatial coordination of gene expression in complex tissues and disentangling overlapping biological processes, such as anatomical organization and disease-associated variation.
Open AccessDissecting the coordinated progression of cell states in spatial transcriptomics with CoPro
Spatial transcriptomics enables the study of how cells coordinate their molecular states within tissue, providing insight into both normal function and disease processes. A key challenge is to identify gene expression programs that vary continuously across space and are coordinated between cell types. We present CoPro , a computational framework for detecting the spatially coordinated progression of cellular states. CoPro can operate in both supervised and unsupervised modes to identify gene programs that co-vary within or between cell types, and to disentangle multiple overlapping spatial patterns. CoPro can be applied to single-cell-level spatial transcriptomics datasets, including MERFISH, SeqFISH+, Xenium, and histology-imputed transcriptomic data. We demonstrate the utility of CoPro with data collected from colon, brain, liver, and kidney tissues. In the colon, CoPro separates epithelial differentiation along the crypt axis from spatially localized inflammatory signals. In the aging liver, it identifies multiple aging-associated cellular programs superimposed on anatomical zonation. In the brain, the flexible kernel design enables the decoupling of the gene expression gradient along the dorsal-ventral and medial-lateral axes. In the kidney, CoPro identifies tubule-vasculature coordination that is essential in nephron function. These results demonstrate CoPro’s utility for analyzing spatial coordination of gene expression in complex tissues and disentangling overlapping biological processes, such as anatomical organization and disease-associated variation.
- Open Access
STDrug enables spatially informed personalized drug repurposing from spatial transcriptomics
Drug repurposing offers a scalable route to accelerate therapeutic discovery, yet existing approaches based on single-cell RNA sequencing (scRNA-seq) often overlook spatial tissue context, limiting their ability to capture microenvironment-dependent drug responses. Here we present STDrug , a spatially informed computational framework that integrates spatial transcriptomics, graph-based modeling, and multimodal learning to enable patient-specific therapeutic prioritization. STDrug identifies and aligns disease and control spatial domains using graph convolutional networks and coherent point drift, and prioritizes candidate drugs through an integrative scoring scheme combining tumor-reversible gene signatures, perturbation-based reversal scores, and knowledge-guided gene weighting within a machine learning framework. By modeling spatial domain interactions alongside predicted drug efficacy and toxicity, STDrug generates robust patient-level drug scores. Across hepatocellular carcinoma and prostate cancer datasets, STDrug outperforms existing single-cell and spatial transcriptomics–based drug repurposing methods, achieving signficantly improved predictive accuracy (AUCs=0.81-0.82) across patients. Validation using large-scale electronic health records and in vitro assays further supports the translational relevance of top-ranked candidates. Taking together, STDrug establishes a generalizable framework for incorporating spatial omics into therapeutic discovery, advancing spatially informed and personalized drug repurposing.
Open AccessSTDrug enables spatially informed personalized drug repurposing from spatial transcriptomics
Drug repurposing offers a scalable route to accelerate therapeutic discovery, yet existing approaches based on single-cell RNA sequencing (scRNA-seq) often overlook spatial tissue context, limiting their ability to capture microenvironment-dependent drug responses. Here we present STDrug , a spatially informed computational framework that integrates spatial transcriptomics, graph-based modeling, and multimodal learning to enable patient-specific therapeutic prioritization. STDrug identifies and aligns disease and control spatial domains using graph convolutional networks and coherent point drift, and prioritizes candidate drugs through an integrative scoring scheme combining tumor-reversible gene signatures, perturbation-based reversal scores, and knowledge-guided gene weighting within a machine learning framework. By modeling spatial domain interactions alongside predicted drug efficacy and toxicity, STDrug generates robust patient-level drug scores. Across hepatocellular carcinoma and prostate cancer datasets, STDrug outperforms existing single-cell and spatial transcriptomics–based drug repurposing methods, achieving signficantly improved predictive accuracy (AUCs=0.81-0.82) across patients. Validation using large-scale electronic health records and in vitro assays further supports the translational relevance of top-ranked candidates. Taking together, STDrug establishes a generalizable framework for incorporating spatial omics into therapeutic discovery, advancing spatially informed and personalized drug repurposing.
- Open Access
A Manifold-Based Measure of Transcriptional Entropy for Quantifying Aging in Single Cells
Characterizing cellular aging is essential for understanding age-related diseases. While tissue-level studies reveal broad age-associated changes, they often reflect compositional shifts rather than cell-level reprogramming. The cellular damage hypothesis posits that aging involves the accumulation of DNA, chromatin, and other damage across molecular layers, increasing transcriptional entropy. Existing supervised methods for detecting cellular senescence yield cell type-specific senescence scores but rely on labeled data and lack generalizability. Here, we introduce a first-principles framework for quantifying transcriptional entropy in single cells as each cell's deviation from a transcriptomic manifold, capturing breakdown of transcriptional coordination. This unsupervised approach identifies aging-affected cell types and distinguishes two cellular aging mechanisms: loss of expression precision and activation of stress-response pathways in high entropy cells. Applied to Tabula Muris Senis and SenNet Multiome datasets, transcriptional entropy correlates with chromatin-based mitotic age and highlights regenerative tissue compartments as most affected by aging.
Open AccessA Manifold-Based Measure of Transcriptional Entropy for Quantifying Aging in Single Cells
Characterizing cellular aging is essential for understanding age-related diseases. While tissue-level studies reveal broad age-associated changes, they often reflect compositional shifts rather than cell-level reprogramming. The cellular damage hypothesis posits that aging involves the accumulation of DNA, chromatin, and other damage across molecular layers, increasing transcriptional entropy. Existing supervised methods for detecting cellular senescence yield cell type-specific senescence scores but rely on labeled data and lack generalizability. Here, we introduce a first-principles framework for quantifying transcriptional entropy in single cells as each cell's deviation from a transcriptomic manifold, capturing breakdown of transcriptional coordination. This unsupervised approach identifies aging-affected cell types and distinguishes two cellular aging mechanisms: loss of expression precision and activation of stress-response pathways in high entropy cells. Applied to Tabula Muris Senis and SenNet Multiome datasets, transcriptional entropy correlates with chromatin-based mitotic age and highlights regenerative tissue compartments as most affected by aging.
- Open Access
Investigate the Effects of Preeclampsia Severity, Race and Fetal Sex on Subsequent Maternal Complications Using EHR Data From Over 100,000 Pregnancies
Preeclampsia (PE) is a major pregnancy complication associated with long‐term maternal health risks, but how these risks vary by severity, race, and fetal sex is unclear. To identify maternal complications after PE and to evaluate the modifying effects of severity, race, and fetal sex, we conducted a retrospective cohort study of over 100,000 patients from four medical centers (UM, UK Biobank, Cedars‐Sinai, Vanderbilt). The discovery cohort included 26,632 UM patients; validation cohorts included 15,313 UK Biobank, 29,821 Cedars‐Sinai, and 31,418 Vanderbilt patients. Thirty potential complications within 10 years postpartum were assessed using confounder‐adjusted logistic regression. Complications persisting ≥ 5 years were further analyzed with Kaplan–Meier survival. Five complications were consistently associated with PE: hypertension, renal failure, diabetes (complicated or uncomplicated), and obesity. Among them, hypertension (median OR = 6.05) and renal failure (median OR = 4.92) showed the strongest associations. Severe PE was linked to earlier and higher risk of hypertension and renal failure. African Americans had lower relative hypertension risk but higher renal failure risk than Caucasians. Fetal sex appeared to modify outcomes: male fetuses conferred a higher maternal hypertension risk but a lower renal failure risk compared with female fetuses.
Open AccessInvestigate the Effects of Preeclampsia Severity, Race and Fetal Sex on Subsequent Maternal Complications Using EHR Data From Over 100,000 Pregnancies
Preeclampsia (PE) is a major pregnancy complication associated with long‐term maternal health risks, but how these risks vary by severity, race, and fetal sex is unclear. To identify maternal complications after PE and to evaluate the modifying effects of severity, race, and fetal sex, we conducted a retrospective cohort study of over 100,000 patients from four medical centers (UM, UK Biobank, Cedars‐Sinai, Vanderbilt). The discovery cohort included 26,632 UM patients; validation cohorts included 15,313 UK Biobank, 29,821 Cedars‐Sinai, and 31,418 Vanderbilt patients. Thirty potential complications within 10 years postpartum were assessed using confounder‐adjusted logistic regression. Complications persisting ≥ 5 years were further analyzed with Kaplan–Meier survival. Five complications were consistently associated with PE: hypertension, renal failure, diabetes (complicated or uncomplicated), and obesity. Among them, hypertension (median OR = 6.05) and renal failure (median OR = 4.92) showed the strongest associations. Severe PE was linked to earlier and higher risk of hypertension and renal failure. African Americans had lower relative hypertension risk but higher renal failure risk than Caucasians. Fetal sex appeared to modify outcomes: male fetuses conferred a higher maternal hypertension risk but a lower renal failure risk compared with female fetuses.
- Open Access
- 16 January 2026
- Published by Oxford University Press (OUP) in GigaScience
- Vol. 15
Cord blood DNA methylation and cell-type composition are not significantly associated with severe preeclampsia after cell-type and clinical covariate adjustment
Background: Preeclampsia is a severe pregnancy complication that threatens maternal and neonatal health and well-being. Previous studies on epigenome-wide association studies (EWAS) of preeclampsia produced inconsistent results in cord blood tissues, and one possible explanation is their failure to rigorously adjust for cell proportions, gestational age, or other necessary variables. Methods: Here, we calculated the DNA methylation changes in cord blood from newborns affected by preeclampsia, using a multi-ethnic cohort from the Hawaii population (24 cases, 38 controls). We comprehensively adjusted for variables, such as maternal age, body mass index, and parity, and estimated the cell proportions. We also re-analyzed 2 previous datasets with adjustments to estimated cell proportions and conducted a pooled analysis by merging all 3 datasets together to increase the statistical power (58 cases, 71 controls). Lastly, we included idiopathic preterm (preterm delivery with no known reasons) cord blood samples (n = 11) to disentangle the effect of severe preeclampsia and small gestational age. Results: We showed that after adjusting cell-type proportions and patient clinical characteristics, most of the so-called statistically significant CpG methylation changes associated with severe preeclampsia disappeared in our own data, 2 public datasets, and the pooled analysis combining all 3 datasets. This result still holds after including idiopathic preterm samples in the control group. Rather, we found that gestation progression is accompanied by statistically significant proportion changes in several cell types, such as granulocytes, nucleated red blood cells (nRBCs), CD8T cells, and B cells, which contribute to most DNA methylation differences between case and control groups. Preeclampsia has interactions on cell proportion changes in granulocytes, monocytes, and nRBCs. Conclusions: In summary, our study shows that the previously reported differentially methylated patterns in cord blood are actually artifacts due to not properly adjusting for cell-type heterogeneity, gestational age, and clinical covariates. Severe preeclampsia is not associated with statistically significant DNA methylation changes but changes in cell proportion. This finding alerts to the scientific rigor needed in EWAS.
- 16 January 2026
- Published by Oxford University Press (OUP) in GigaScience
- Vol. 15
Open AccessCord blood DNA methylation and cell-type composition are not significantly associated with severe preeclampsia after cell-type and clinical covariate adjustment
Background: Preeclampsia is a severe pregnancy complication that threatens maternal and neonatal health and well-being. Previous studies on epigenome-wide association studies (EWAS) of preeclampsia produced inconsistent results in cord blood tissues, and one possible explanation is their failure to rigorously adjust for cell proportions, gestational age, or other necessary variables. Methods: Here, we calculated the DNA methylation changes in cord blood from newborns affected by preeclampsia, using a multi-ethnic cohort from the Hawaii population (24 cases, 38 controls). We comprehensively adjusted for variables, such as maternal age, body mass index, and parity, and estimated the cell proportions. We also re-analyzed 2 previous datasets with adjustments to estimated cell proportions and conducted a pooled analysis by merging all 3 datasets together to increase the statistical power (58 cases, 71 controls). Lastly, we included idiopathic preterm (preterm delivery with no known reasons) cord blood samples (n = 11) to disentangle the effect of severe preeclampsia and small gestational age. Results: We showed that after adjusting cell-type proportions and patient clinical characteristics, most of the so-called statistically significant CpG methylation changes associated with severe preeclampsia disappeared in our own data, 2 public datasets, and the pooled analysis combining all 3 datasets. This result still holds after including idiopathic preterm samples in the control group. Rather, we found that gestation progression is accompanied by statistically significant proportion changes in several cell types, such as granulocytes, nucleated red blood cells (nRBCs), CD8T cells, and B cells, which contribute to most DNA methylation differences between case and control groups. Preeclampsia has interactions on cell proportion changes in granulocytes, monocytes, and nRBCs. Conclusions: In summary, our study shows that the previously reported differentially methylated patterns in cord blood are actually artifacts due to not properly adjusting for cell-type heterogeneity, gestational age, and clinical covariates. Severe preeclampsia is not associated with statistically significant DNA methylation changes but changes in cell proportion. This finding alerts to the scientific rigor needed in EWAS.